News & insights

Calculation of SPC term in EU accession countries

Data exclusivity for innovators - a bridge too far?

by Andrew Payne

Pemetrexed in Germany: Federal Court of Justice sets aside decision of Appeal Court

by Christoph de Coster, LL.M. (UC Davis) and Julius Zacharias

CJEU confirms orphan drug market exclusivity

by Matthew Royle, Ph.D.

Biosimilars and the issue of duplicates

by Dr Paul England and Matthew Royle, Ph.D.

Intellectual Property in the Life Sciences, in review

by Dr Paul England

The implementation of the Nagoya Protocol in the EU

by Verena Bertram

The implementation of the Nagoya Protocol in Germany

by Verena Bertram

Upgrading the single market: updating the Bolar exemption

by Dr Paul England